Author Correction: Mutations in viral nucleocapsid protein and endoRNase are discovered to associate with COVID19 hospitalization risk

Sci Rep. 2022 Feb 22;12(1):3274. doi: 10.1038/s41598-022-07002-z.

Lue Ping Zhao^#¹, Pavitra Roychoudhury^#^{2

3}, Peter Gilbert^{4

2}, Joshua Schiffer⁵, Terry P Lybrand^{6

7}, Thomas H Payne⁸, April Randhawa², Sara Thiebaud², Margaret Mills², Alex Greninger², Chul-Woo Pyo^{5

9}, Ruihan Wang^{5

9}, Renyu Li^{5

9}, Alexander Thomas^{5

9}, Brandon Norris^{5

9}, Wyatt C Nelson^{5

9}, Keith R Jerome^{2

3}, Daniel E Geraghty^{10

11}

¹ Division of Public Health Sciences, Fred Hutch Cancer Center, Seattle, WA, 98109, USA. lzhao@fredhutch.org.
² Vaccine and Infectious Disease Division, Fred Hutch Cancer Center, Seattle, WA, 98109, USA.
³ Department of Laboratory Medicine and Pathology, University of Washington School of Medicine, Seattle, WA, USA.
⁴ Division of Public Health Sciences, Fred Hutch Cancer Center, Seattle, WA, 98109, USA.
⁵ Clinical Research Division, Fred Hutch Cancer Center, Seattle, WA, 98109, USA.
⁶ Quintepa Computing LLC, Nashville, TN, USA.
⁷ Department of Chemistry, Department of Pharmacology, Vanderbilt University, Nashville, TN, USA.
⁸ Department of Medicine, University of Washington School of Medicine, Seattle, WA, USA.
⁹ Scisco Genetics Inc., Seattle, WA, 98102, USA.
¹⁰ Clinical Research Division, Fred Hutch Cancer Center, Seattle, WA, 98109, USA. geraghty@fredhutch.org.
¹¹ Scisco Genetics Inc., Seattle, WA, 98102, USA. geraghty@fredhutch.org.

^# Contributed equally.

No abstract available

Publication types